This site is intended for healthcare professionals only
LoginRegister
Biocon Launches Denosumab Biosimilars Bosaya, Aukelso in USBiocon Launches Denosumab Biosimilars Bosaya, Aukelso in US
Lupin, Zydus Secure USFDA Nod for Dapagliflozin TabletsLupin, Zydus Secure USFDA Nod for Dapagliflozin Tablets
Lokayukta Raids Assistant Drug Controller, Unearths Rs 3.37 Crore Disproportionate AssetsLokayukta Raids Assistant Drug Controller, Unearths Rs 3.37 Crore Disproportionate Assets
Illegal Stockpiling Busted: Pregabalin, Alprazolam Medicines Seized in Ludhiana RaidIllegal Stockpiling Busted: Pregabalin, Alprazolam Medicines Seized in Ludhiana Raid
Gilead to Acquire Tubulis for USD 5 Billion to Strengthen Cancer PipelineGilead to Acquire Tubulis for USD 5 Billion to Strengthen Cancer Pipeline
Dr ReddyDr Reddy's Divests Svaas Wellness Stake to Enspirit for Rs 2.23 Crore
Aurobindo Pharma Secures USFDA Nod for Dapagliflozin-Metformin XR, Gains 180-Day ExclusivityAurobindo Pharma Secures USFDA Nod for Dapagliflozin-Metformin XR, Gains 180-Day Exclusivity
USFDA Approves Alembics Dapagliflozin Tablets, Grants 180-Day ExclusivityUSFDA Approves Alembic's Dapagliflozin Tablets, Grants 180-Day Exclusivity
2.5 Million Jobs by 2030 in Pharma, Healthcare as Sector Shifts to Skill-Led Growth: Report2.5 Million Jobs by 2030 in Pharma, Healthcare as Sector Shifts to Skill-Led Growth: Report
Wegovy HD Rollout: Novo Nordisk Introduces 7.2 mg Dose in US MarketWegovy HD Rollout: Novo Nordisk Introduces 7.2 mg Dose in US Market
AstraZenecas Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer TrialAstraZeneca's Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer Trial
Granules Indias US Arm Gets 4 USFDA ObservationsGranules India's US Arm Gets 4 USFDA Observations
X